These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. CHART in non-small-cell lung cancer: INCHing forward. Hatton M; Stephens R Clin Oncol (R Coll Radiol); 2005 Jun; 17(4):207-9. PubMed ID: 15997912 [No Abstract] [Full Text] [Related]
3. Reasons for the slow implementations of CHART for patients with non-small cell lung cancer in clinical practice. Ball DL; Peters LJ; Smith J Radiother Oncol; 2001 Jan; 58(1):89-90. PubMed ID: 11258342 [No Abstract] [Full Text] [Related]
4. Stage III nonsmall cell lung cancer: still a challenge for the radiation oncologist. Van Houtte P Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):533-5. PubMed ID: 9336128 [No Abstract] [Full Text] [Related]
5. In regard to Jeremic et al., IJROBP 2001;50:19-25. Thomas CR Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1145; author reply 1145-6. PubMed ID: 11958919 [No Abstract] [Full Text] [Related]
7. The role of radiotherapy and the value of combined treatment in lung cancer. Van Houtte P Eur J Cancer; 2001 Oct; 37 Suppl 7():S91-8. PubMed ID: 11888009 [No Abstract] [Full Text] [Related]
8. In regard to hyperfractionation for non-small-cell lung cancer: fire, ready, aim! Beitler JJ Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1460; author reply 1460-1. PubMed ID: 12654462 [No Abstract] [Full Text] [Related]
9. Radiation therapy for non-small cell lung cancer (NSCLC). Choy H; Chakravarthy A; Kim JS Cancer Treat Res; 2001; 105():121-48. PubMed ID: 11224985 [No Abstract] [Full Text] [Related]
10. Fatal pulmonary fibrosis associated with induction chemotherapy with carboplatin and vinorelbine followed by CHART radiotherapy for locally advanced non-small cell lung cancer. Kirkbride P; Hatton M; Lorigan P; Joyce P; Fisher P Clin Oncol (R Coll Radiol); 2002 Oct; 14(5):361-6. PubMed ID: 12555874 [TBL] [Abstract][Full Text] [Related]
11. Progress in unresectable stage III non-small cell lung cancer. Vokes EE Cancer J Sci Am; 1996; 2(6):304-6. PubMed ID: 9166548 [No Abstract] [Full Text] [Related]
12. Oesophageal toxicity and hypofractionated concurrent chemoradiotherapy for non-small cell lung cancer. Tho LM; Mahmood R; Leitch M; Brisbane I; Kakumanu S; Mohammed N Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):74. PubMed ID: 18986800 [No Abstract] [Full Text] [Related]
13. Long term results of CHART and weekly Paclitaxel in locally advanced non-small cell lung cancer. Oral EN Lung Cancer; 2005 Sep; 49(3):421-2. PubMed ID: 16102609 [No Abstract] [Full Text] [Related]
14. Dose fractionation and biological optimization in lung cancer. Trodella L; D'Angelillo RM; Ramella S; Ciresa M; Massaccesi M Rays; 2004; 29(3):319-26. PubMed ID: 15603304 [TBL] [Abstract][Full Text] [Related]